Primitive neuroectodermal tumor of the cervix uteri

disease
On this page

Also known as cervical malignant peripheral neuroectodermal tumorcervical malignant peripheral neuroectodermal tumourcervical peripheral neuroectodermal cancermalignant peripheral neuroectodermal tumor of the cervix uterimalignant peripheral neuroectodermal tumour of the cervix uteriperipheral neuroectodermal cancer of cervix uteri

Summary

Primitive neuroectodermal tumor of the cervix uteri (MONDO:0016284) is a cancer. A subtype of sarcoma of cervix uteri — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer
  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Annual incidence<1 / 1 000 000WorldwideValidated

Identifiers

Disease identifiers

FieldValue
Canonical nameprimitive neuroectodermal tumor of the cervix uteri
Mondo IDMONDO:0016284
Orphanet213812
UMLSC4707725
MedGen1636418
GARD0020496
Is cancer (heuristic)yes

Also known as: cervical malignant peripheral neuroectodermal tumor · cervical malignant peripheral neuroectodermal tumour · cervical peripheral neuroectodermal cancer · malignant peripheral neuroectodermal tumor of the cervix uteri · malignant peripheral neuroectodermal tumour of the cervix uteri · peripheral neuroectodermal cancer of cervix uteri

Disease family

This is a subtype of sarcoma of cervix uteri. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease by etiologic mechanism › cancer or benign tumorneoplastic disease or syndromeneoplasmcancerreproductive system cancerfemale reproductive organ canceruterine cancercervical cancersarcoma of cervix uteriprimitive neuroectodermal tumor of the cervix uteri

Related subtypes (4): cervical alveolar soft part sarcoma, endometrioid stromal sarcoma of the cervix, rhabdomyosarcoma of the cervix uteri, leiomyosarcoma of the cervix uteri

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.